Discover
BBNX
Beta Bionics, Inc.
21.89
2 x 10.42
2 x 17.63
bid
ask
+
0.46
2.15%
2 @ 07:30 PM
21.87 -0.02 (0.09%)
| Ytd | -28.16% | |
| 1y | -5.03% |
21.10
day range
22.16
8.86
52 week range
31.99
| Open | 21.30 | Prev Close | 21.43 | Low | 21.10 | High | 22.16 | Mkt Cap | 1.15B |
| Vol | 1.53M | Avg Vol | 1.29M | EPS | -1.60 | P/E | N/A | Forward P/E | -9.42 |
| Beta | 3.37 | Short Ratio | 7.49 | Inst. Own | 95.84% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 10-27 | 50-d Avg | 17.50 | 200-d Avg | 16.29 | 1yr Est | 22.40 |
| Income Statement | |||
| Total Revenue | 32.01M | ||
| Revenues (USD) | 32.01M | ||
| Cost of Revenue | 13.11M | ||
| Gross Profit | 18.90M | ||
| Operating Expenses | 44.48M | ||
| Research and Development Expense | 10.24M | ||
| Selling, General and Administrative Expense | 34.24M | ||
| Operating Income | -25.58M | ||
| Net Income | -23.40M | ||
| Net Income Common Stock | -23.40M | ||
| Net Income Common Stock (USD) | -23.40M | ||
| Consolidated Income | -23.40M | ||
| Earnings per Basic Share | -0.53 | ||
| Earnings per Basic Share (USD) | -0.53 | ||
| Earnings per Diluted Share | -0.53 | ||
| Earning Before Interest & Taxes (EBIT) | -23.40M | ||
| Earning Before Interest & Taxes (USD) | -23.40M | ||
| Weighted Average Shares | 44.55M | ||
| Weighted Average Shares Diluted | 44.55M | ||
| Balance Sheet | |||
| Cash and Equivalents | 44.42M | ||
| Cash and Equivalents (USD) | 44.42M | ||
| Investments | 180.82M | ||
| Investments Current | 136.17M | ||
| Investments Non-Current | 44.65M | ||
| Trade and Non-Trade Receivables | 18.05M | ||
| Current Assets | 231.03M | ||
| Property, Plant & Equipment Net | 16.56M | ||
| Total Assets | 292.39M | ||
| Debt Current | 1.59M | ||
| Total Debt | 6.51M | ||
| Current Liabilities | 26.02M | ||
| Debt Non-Current | 4.92M | ||
| Total Liabilities | 36.02M | ||
| Accumulated Retained Earnings (Deficit) | -415.23M | ||
| Accumulated Other Comprehensive Income | -390.00K | ||
| Shareholders Equity | 256.37M | ||
| Shareholders Equity (USD) | 256.37M | ||
| Assets Non-Current | 61.35M | ||
| Total Debt (USD) | 6.51M | ||
| Deferred Revenue | 5.34M | ||
| Inventory | 23.92M | ||
| Liabilities Non-Current | 10.00M | ||
| Trade and Non-Trade Payables | 5.35M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 1.12M | ||
| Net Cash Flow from Financing | 1.80M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 14.11M | ||
| Capital Expenditure | -1.04M | ||
| Issuance (Purchase) of Equity Shares | 1.80M | ||
| Net Cash Flow from Investing | 26.93M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 27.97M | ||
| Net Cash Flow from Operations | -14.62M | ||
| Share Based Compensation | 7.02M | ||